Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2019

Open Access 01-12-2019 | Research article

Medication management support in diabetes: a systematic assessment of diabetes self-management apps

Authors: Zhilian Huang, Elaine Lum, Geronimo Jimenez, Monika Semwal, Peter Sloot, Josip Car

Published in: BMC Medicine | Issue 1/2019

Login to get access

Abstract

Background

Smartphone apps are becoming increasingly popular for supporting diabetes self-management. A key aspect of diabetes self-management is appropriate medication-taking. This study aims to systematically assess and characterise the medication management features in diabetes self-management apps and their congruence with best-practice evidence-based criteria.

Methods

The Google Play and Apple app stores were searched in June 2018 using diabetes-related terms in the English language. Apps with both medication and blood glucose management features were downloaded and evaluated against assessment criteria derived from international medication management and diabetes guidelines.

Results

Our search yielded 3369 Android and 1799 iOS potentially relevant apps; of which, 143 apps (81 Android, 62 iOS) met inclusion criteria and were downloaded and assessed. Over half 58.0% (83/143) of the apps had a medication reminder feature; 16.8% (24/143) had a feature to review medication adherence; 39.9% (57/143) allowed entry of medication-taking instructions; 5.6% (8/143) provided information about medication; and 4.2% (6/143) displayed motivational messages to encourage medication-taking. Only two apps prompted users on the use of complementary medicine. Issues such as limited medication logging capacity, faulty reminder features, unclear medication adherence assessment, and visually distracting excessive advertising were observed during app assessments.

Conclusions

A large proportion of diabetes self-management apps lacked features for enhancing medication adherence and safety. More emphasis should be given to the design of medication management features in diabetes apps to improve their alignment to evidence-based best practice.
Appendix
Available only for authorised users
Literature
1.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.CrossRef
2.
Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.CrossRef
3.
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.CrossRef
4.
Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269.PubMedPubMedCentral
5.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014(11).
6.
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53(2):172–81.CrossRef
7.
Thakkar J, Kurup R, Laba T-L, Santo K, Thiagalingam A, Rodgers A, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. 2016;176(3):340–9.CrossRef
8.
Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932–53.CrossRef
9.
Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, De Walque D, Mackeen L, Haberer J, Kimaiyo S, Sidle J. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS (London, England). 2011;25(6):825.CrossRef
10.
Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, van Wingerden P, Bouvy ML, et al. SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform. 2012;81(9):594–604.CrossRef
11.
12.
13.
Car J, Tan WS, Huang Z, Sloot P, Franklin BD. eHealth in the future of medications management: personalisation, monitoring and adherence. BMC Med. 2017;15(1):73.CrossRef
14.
Ahmed I, Ahmad NS, Ali S, Ali S, George A, Danish HS, Uppal E, Soo J, Mobasheri MH, King D. Medication adherence apps: review and content analysis. JMIR mHealth UHealth. 2018;6(3):e62.CrossRef
15.
Santo K, Richtering SS, Chalmers J, Thiagalingam A, Chow CK, Redfern J. Mobile phone apps to improve medication adherence: a systematic stepwise process to identify high-quality apps. JMIR mHealth UHealth. 2016;4(4):e132.CrossRef
16.
17.
18.
Lum E, Jimenez G, Huang Z, Thai L, Semwal M, Boehm BO, Car J. Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes app-based decision support and alerts for blood glucose self-management in type 2 DiabetesLetters. JAMA. 2019;321(15):1530–2.CrossRef
19.
Jimenez G, Lum E, Car J. Examining diabetes management apps recommended from a Google search: content analysis. JMIR mHealth UHealth. 2019;7(1):e11848.CrossRef
20.
National Institute for Health and Care Excellence N: Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. In. http://​nice.​org.​uk/​guidance/​ng5. National Institute for Health and Care Excellence; 2015. Accessed 25 Jan 2019.
21.
Nunes V, Neilson J, O’flynn N, Calvert N, Kuntze S, Smithson H, Benson J, Blair J, Bowser A, Clyne W. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009. p. 364.
22.
Usherwood T. Encouraging adherence to long-term medication. Aust Prescr. 2017;40(4):147.CrossRef
23.
Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.CrossRef
24.
Duerden M, Avery T, Payne R: Polypharmacy and medicines optimisation. Making it safe and sound London: the King’s fund 2013.
25.
National Institute for Health and Care Excellence N: Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. In. https://​www.​nice.​org.​uk/​guidance/​cg76. National Institute for Health and Care Excellence; 2009. Accessed 25 Jan 2019.
26.
Ruppar TM, Dobbels F, Lewek P, Matyjaszczyk M, Siebens K, De Geest SM. Systematic review of clinical practice guidelines for the improvement of medication adherence. Int J Behav Med. 2015;22(6):699–708.CrossRef
27.
Bosworth HB, Zullig LL, Mendys P, Ho M, Trygstad T, Granger C, Oakes MM, Granger BB. Health information technology: meaningful use and next steps to improving electronic facilitation of medication adherence. JMIR Med Inform. 2016;4(1):e9.CrossRef
28.
Australian Pharmaceutical Advisory Council. Guiding principles for medication management in the community. Canberra: Commonwealth of Australia; 2006.
29.
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RC, Coker-Schwimmer EJ, Grodensky CA, Rosen DL, Yuen A. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness); 2012.
30.
Stowasser DA, Allinson YM, O'Leary M. Understanding the medicines management pathway. J Pharm Pract Res. 2004;34(4):293–6.CrossRef
31.
McHugh ML. Interrater reliability: the kappa statistic. Biochemia Med. 2012;22(3):276–82.CrossRef
32.
Corp I. IBM SPSS statistics for windows, version 22.0. Armonk: IBM Corp; 2013.
33.
Martinez M, Park SB, Maison I, Mody V, Soh LS, Parihar HS. iOS Appstore-based phone apps for diabetes management: potential for use in medication adherence. JMIR Diabetes. 2017;2(2):e12.CrossRef
34.
Soljak M, Lum E, Huang Z, Jiminez G, Li L, Sng MK, Semwal M, Thai ML, Bajpai S, Zhang J, et al. Developing a global assessment framework for health apps targeted at elderly users with type 2 diabetes mellitus. In: 2nd ARISE RESEARCH SYMPOSIUM Healthy & Active community and Ageing Workforce: Ageing Research Institute for Society and Education, Nanyang Technological Univerisity; 2018.
35.
Covington MB. Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectrum. 2001;14(3):154.CrossRef
36.
Becker S, Kribben A, Meister S, Diamantidis CJ, Unger N, Mitchell A. User profiles of a smartphone application to support drug adherence—experiences from the iNephro project. PLoS One. 2013;8(10):e78547.CrossRef
37.
Mira JJ, Navarro I, Botella F, Borrás F, Nuño-Solinís R, Orozco D, Iglesias-Alonso F, Pérez-Pérez P, Lorenzo S, Toro N. A Spanish pillbox app for elderly patients taking multiple medications: randomized controlled trial. J Med Internet Res. 2014;16(4):e99.CrossRef
38.
Sarbacker GB, Urteaga EM. Adherence to insulin therapy. Diabetes Spectrum. 2016;29(3):166.CrossRef
39.
Davies M, Gagliardino JJ, Gray L, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabetic Med. 2013;30(5):512–24.CrossRef
40.
Huckvale K, Morrison C, Ouyang J, Ghaghda A, Car J. The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med. 2015;13:58.
41.
Bates DW, Landman A, Levine DM. Health apps and health policy: what is needed?Health apps and health policy health apps and health policy. JAMA. 2018;320(19):1975–6.CrossRef
Metadata
Title
Medication management support in diabetes: a systematic assessment of diabetes self-management apps
Authors
Zhilian Huang
Elaine Lum
Geronimo Jimenez
Monika Semwal
Peter Sloot
Josip Car
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2019
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-019-1362-1

Other articles of this Issue 1/2019

BMC Medicine 1/2019 Go to the issue

Research article

Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care

Research article

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity

Research article

Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria

Commentary

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers

Correction

Correction to: How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use?

Research article

A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections